Pathogen reporting can often be delayed or inaccurate, leaving locally trained health professionals unable to diagnose dangerous viruses that present with fever, aches and nausea, which are all common symptoms for Zika, Malaria and the Flu.
Global health surveillance is essential, providing vital data on disease incidence and drug resistance. However, data collection can be a sizeable undertaking, placing an additional burden on already stretched – and often under resourced – healthcare professionals.
In addition, surveillance of antibiotic resistance generally is neither coordinated nor harmonised, compromising the ability to assess and monitor the situation.”
Imagine being able to contain an outbreak of a novel virus before it became a global epidemic.
Imagine the world’s healthcare systems were one step ahead of antibiotic resistance.
Imagine researchers had the data they need to develop and test novel disease management interventions.
The connectivity of globally distributed Q-POC™ devices will make this possible.
As a future development, we envisage that globally distributed Q-POC™ devices will geotag and anonymise pathogen data, then send it to the cloud for real-time disease and drug resistance monitoring.
Just as the internet has revolutionised how we share information, this global surveillance system will transform the way we share genomic data.
This data will be used to monitor the spread of antimicrobial resistance, detect and contain a novel disease outbreak, and identify suitable targets for drug development.